BEIJING, Sept. 27,
2024 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman"
or the "Company"), a leading provider of tech-powered, intellectual
development products in China,
today announced its unaudited financial results for the second
quarter ended June 30, 2024.
Second Quarter 2024 Highlights
- Revenues were RMB215.1 million
(US$29.6 million), compared with
RMB241.0 million in the same period
last year.
- Gross profit was RMB151.7 million
(US$20.9 million), compared with
RMB170.8 million in the same period
last year.
- Operating income was RMB18.8
million (US$2.6 million),
compared with RMB40.9 million in the
same period last year.
- Net income was RMB24.7 million
(US$3.4 million), compared with
RMB42.1 million in the same period
last year.
- Average total MAUs[1] for the second quarter were
24.57 million, a year-over-year increase of 20.8%.
[1] "Average total
MAUs" refers to the monthly average of the sum of the MAUs of each
of the Company's apps during a specific period, which is counted
based on the number of unique mobile devices through which such app
is accessed at least once in a given month, and duplicate access to
different apps is not eliminated from the total MAUs
calculation.
|
Dr. Peng Dai,
Director and Chief Executive Officer of iHuman, commented, "In the
second quarter, we made steady progress in advancing our strategic
priorities, intensifying efforts across multiple fronts to build
momentum for our sustainable
growth.
In the domestic market, we expanded our smart
device lineup with the introduction of the iHuman Pinyin Reader, which is designed to help
kids master Pinyin through high-quality content, interactive
hands-on experiences, and engaging exercises. The product features
catchy pinyin mnemonics to enhance memory retention and offers
audio and visual challenges to make learning more engaging. The
iHuman Pinyin Reader uses
Pinyin as a gateway to introduce nursery rhymes and foundational
Chinese classical studies. Its proprietary rating system also
assigns children to different proficiency levels, keeping kids
motivated while making it easy for parents to track progress.
Our international expansion continued to gain
momentum as we enriched our content library with new themes that
appeal to young audiences worldwide. In Aha Makeover, we
launched "Mermaid Melody" and "Forest Fantasy," two themes that
combine imaginative elements like whimsical mermaids and enchanting
forests with a variety of interactive features. In Gogo Mini World, the new theme "Fashion
Salon" offers a dynamic platform for creative expression through
beauty and styling activities, allowing children to share photos of
their unique fashion designs. Furthermore, the new theme
"Princess Castle" introduces a
magical touch with magic wand play and customizable fireworks.
These new themes are particularly engaging for children as they
offer a mix of fantasy, creativity, and interactive fun,
encouraging them to explore their interests and unleash their
imaginations.
During the quarter, our animation studio Kunpeng
also made notable headway internationally with its Cosmicrew
franchise. Following a successful run on major TV networks and
streaming platforms in China, the
Cosmicrew animated series has now expanded into several
global markets, including the United
States, the United Kingdom,
Australia, and Singapore. The franchise's international reach
was further extended with the Cosmicrew movie, which, after
its premiere in China in 2023, has
also been screened this year in several European countries. This
global expansion not only boosts Kunpeng's international visibility
and brand recognition, but also supports our broader international
business strategy, thereby solidifying our presence in key global
markets.
The progress we achieved across markets and
business lines in the second quarter underscores our effective
execution and commitment to long-term growth. Moving forward, we
will continue to build on core strengths and leverage our extensive
product portfolio to drive market expansion and business growth,"
concluded Dr. Dai.
Ms. Vivien Weiwei
Wang, Director and Chief Financial Officer of iHuman, added,
"In the second quarter of 2024, we recorded our tenth consecutive
quarter of profitability. We also ended the quarter with
RMB1.13 billion in cash, cash
equivalents, and time deposits. With our healthy financial
position, we have the privilege to accelerate our innovation
efforts in pioneering content and technologies, ensuring that we
remain at the forefront of technological developments and emerging
trends to welcome and accommodate the evolving needs and
preferences of users. For instance, during the quarter, we
developed an experimental product specifically designed for use
with Apple's Vision Pro, establishing ourselves as an industry
pioneer in exploring applications compatible with this
revolutionary headset. By harnessing the Vision Pro's immersive
spatial environment, precise eye tracking, and gesture capture
functions, we deliver even more interactive and captivating
experiences for children. On the operational front, we calibrated
our sales and marketing efforts to align with our expanded efforts
on new product development and launches. Notably, we have
strengthened collaborations with leading manufacturers of learning
pads, smart speakers, tablets, and even smart cars to pre-install
our app products. As smart devices become increasingly integral to
daily life, we expect these partnerships to extend our market
coverage and make our offerings more accessible to families.
Looking ahead to the second half of the year, we will continue to
invest strategically in product innovation and global brand
recognition to build a sustainable growth engine for our
business."
Second Quarter 2024 Unaudited Financial Results
Revenues
Revenues were RMB215.1 million
(US$29.6 million), a decrease of
10.7% from RMB241.0 million in the
same period last year, primarily due to more conservative consumer
spending.
Average total MAUs for the quarter were 24.57 million, an
increase of 20.8% year-over-year from 20.33 million in the same
period last year, primarily due to the
effective execution of our user acquisition strategy.
Cost of Revenues
Cost of revenues was RMB63.4
million (US$8.7 million), a
decrease of 9.7% from RMB70.2 million
in the same period last year, primarily due to decreased channel
costs.
Gross Profit and Gross Margin
Gross profit was RMB151.7 million
(US$20.9 million), compared with
RMB170.8 million in the same period
last year. Gross margin was 70.5%, compared with 70.9% in the same
period last year.
Operating Expenses
Total operating expenses were RMB132.9
million (US$18.3 million),
compared to RMB130.0 million in the
same period last year.
Research and development expenses were RMB57.2 million (US$7.9
million), a decrease of 9.8% from RMB63.4 million in the same period last year,
primarily due to decreased payroll related expenses.
Sales and marketing expenses were RMB51.3
million (US$7.1 million), an
increase of 26.4% from RMB40.6
million in the same period last year, primarily due to
increased strategic spending on promotional activities, brand
enhancement, and overseas expansion.
General and administrative expenses were RMB24.4 million (US$3.4
million), a decrease of 6.0% from RMB26.0 million in the same period last year,
primarily due to decreases in share-based compensation expenses, as
well as other administrative expenses.
Operating Income
Operating income was RMB18.8
million (US$2.6 million),
compared with RMB40.9 million in the
same period last year.
Net Income
Net income was RMB24.7 million
(US$3.4 million), compared with
RMB42.1 million in the same period
last year.
Basic and diluted net income per ADS were RMB0.47 (US$0.06)
and RMB0.45 (US$0.06), respectively, compared with
RMB0.80 and RMB0.77 in the same period last year. Each ADS
represents five Class A ordinary shares of the Company.
Deferred Revenue and Customer
Advances
Deferred revenue and customer advances were RMB289.9 million (US$39.9
million) as of June 30, 2024,
compared with RMB318.6 million as of
December 31, 2023.
Cash, Cash Equivalents and Time Deposits
Cash, cash equivalents and time deposits were RMB1,129.4 million (US$155.4 million) as of June 30, 2024, compared with RMB1,213.8 million as of December 31, 2023. The decrease was primarily due
to the payment of annual bonuses to employees in the first
quarter.
Exchange Rate Information
The U.S. dollar (US$) amounts disclosed in this press release,
except for those transaction amounts that were actually settled in
U.S. dollars, are presented solely for the convenience of the
reader. The conversion of Renminbi (RMB) into US$ in this press
release is based on the exchange rate set forth in the H.10
statistical release of the Board of Governors of the Federal
Reserve System as of June 28, 2024,
which was RMB7.2672 to US$1.00. The percentages stated in this press
release are calculated based on the RMB amounts.
Non-GAAP Financial Measures
iHuman considers and uses non-GAAP financial measures, such as
adjusted operating income, adjusted net income and adjusted diluted
net income per ADS, as supplemental metrics in reviewing and
assessing its operating performance and formulating its business
plan. The presentation of non-GAAP financial measures is not
intended to be considered in isolation or as a substitute for the
financial information prepared and presented in accordance with
accounting principles generally accepted in the United States of America ("U.S. GAAP").
iHuman defines adjusted operating income, adjusted net income and
adjusted diluted net income per ADS as operating income, net income
and diluted net income per ADS excluding share-based compensation
expenses, respectively. Adjusted operating income, adjusted net
income and adjusted diluted net income per ADS enable iHuman's
management to assess its operating results without considering the
impact of share-based compensation expenses, which are non-cash
charges. iHuman believes that these non-GAAP financial measures
provide useful information to investors in understanding and
evaluating the Company's current operating performance and
prospects in the same manner as management does, if they so
choose.
Non-GAAP financial measures are not defined under U.S. GAAP and
are not presented in accordance with U.S. GAAP. Non-GAAP financial
measures have limitations as analytical tools, which possibly do
not reflect all items of expense that affect our operations.
Share-based compensation expenses have been and may continue to be
incurred in our business and are not reflected in the presentation
of the non-GAAP financial measures. In addition, the non-GAAP
financial measures iHuman uses may differ from the non-GAAP
measures used by other companies, including peer companies, and
therefore their comparability may be limited. The presentation of
these non-GAAP financial measures is not intended to be considered
in isolation from or as a substitute for the financial information
prepared and presented in accordance with GAAP.
Safe Harbor Statement
This announcement contains forward-looking statements. These
statements are made under the "safe harbor" provisions of the
United States Private Securities Litigation Reform Act of 1995.
These forward-looking statements can be identified by terminology
such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar statements.
Statements that are not historical facts, including statements
about iHuman's beliefs and expectations, are forward-looking
statements. Among other things, the description of the management's
quotations in this announcement contains forward-looking
statements. iHuman may also make written or oral forward-looking
statements in its periodic reports to the U.S. Securities and
Exchange Commission (the "SEC"), in its annual report to
shareholders, in press releases and other written materials, and in
oral statements made by its officers, directors or employees to
third parties. Forward-looking statements involve inherent risks
and uncertainties. A number of factors could cause actual results
to differ materially from those contained in any forward-looking
statement, including but not limited to the following: iHuman's
growth strategies; its future business development, financial
condition and results of operations; its ability to continue to
attract and retain users, convert non-paying users into paying
users and increase the spending of paying users, the trends in, and
size of, the market in which iHuman operates; its expectations
regarding demand for, and market acceptance of, its products and
services; its expectations regarding its relationships with
business partners; general economic and business conditions;
regulatory environment; and assumptions underlying or related to
any of the foregoing. Further information regarding these and other
risks is included in iHuman's filings with the SEC. All information
provided in this press release is as of the date of this press
release, and iHuman does not undertake any obligation to update any
forward-looking statement, except as required under applicable
law.
About iHuman Inc.
iHuman Inc. is a leading provider of tech-powered, intellectual
development products in China that
is committed to making the child-upbringing experience easier for
parents and transforming intellectual development into a fun
journey for children. Benefiting from a deep legacy that combines
over two decades of experience in the parenthood industry, superior
original content, advanced high-tech innovation DNA and research
& development capabilities with cutting-edge technologies,
iHuman empowers parents with tools to make the child-upbringing
experience more efficient. iHuman's unique, fun and interactive
product offerings stimulate children's natural curiosity and
exploration. The Company's comprehensive suite of innovative and
high-quality products include self-directed apps, interactive
content and smart devices that cover a broad variety of areas to
develop children's abilities in speaking, critical thinking,
independent reading and creativity, and foster their natural
interest in traditional Chinese culture. Leveraging advanced
technological capabilities, including 3D engines, AI/AR
functionality, and big data analysis on children's behavior &
psychology, iHuman believes it will continue to provide superior
experience that is efficient and relieving for parents, and
effective and fun for children, in China and all over the world, through its
integrated suite of tech-powered, intellectual development
products.
For more information about iHuman, please visit
https://ir.ihuman.com/.
For investor and media enquiries, please contact:
iHuman Inc.
Mr. Justin Zhang
Investor Relations Director
Phone: +86 10 5780-6606
E-mail: ir@ihuman.com
Christensen
In China
Ms. Alice Li
Phone: +86-10-5900-1548
E-mail: alice.li@christensencomms.com
In the US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
E-mail: linda.bergkamp@christensencomms.com
iHuman Inc.
|
UNAUDITED CONDENSED
CONSOLIDATED BALANCE SHEETS
|
|
(Amounts in
thousands of Renminbi ("RMB") and U.S. dollars
("US$")
|
except for number of
shares, ADSs, per share and per ADS
data)
|
|
|
December
31,
|
|
June
30,
|
|
June
30,
|
|
2023
|
|
2024
|
|
2024
|
|
RMB
|
|
RMB
|
|
US$
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
Current
assets
|
|
|
|
|
|
Cash and cash
equivalents
|
1,213,767
|
|
914,474
|
|
125,836
|
Time
deposits
|
-
|
|
214,944
|
|
29,577
|
Accounts receivable,
net
|
60,832
|
|
52,440
|
|
7,216
|
Inventories,
net
|
16,518
|
|
19,070
|
|
2,624
|
Amounts due from
related parties
|
1,810
|
|
1,773
|
|
244
|
Prepayments and other
current assets
|
89,511
|
|
93,971
|
|
12,931
|
Total current
assets
|
1,382,438
|
|
1,296,672
|
|
178,428
|
Non-current
assets
|
|
|
|
|
|
Property and
equipment, net
|
6,169
|
|
4,643
|
|
639
|
Intangible assets,
net
|
23,245
|
|
20,430
|
|
2,811
|
Operating lease
right-of-use assets
|
3,648
|
|
2,811
|
|
387
|
Long-term
investment
|
26,333
|
|
26,333
|
|
3,624
|
Other non-current
assets
|
8,662
|
|
7,981
|
|
1,098
|
Total non-current
assets
|
68,057
|
|
62,198
|
|
8,559
|
Total
assets
|
1,450,495
|
|
1,358,870
|
|
186,987
|
|
|
|
|
|
|
LIABILITIES
|
|
|
|
|
|
Current
liabilities
|
|
|
|
|
|
Accounts
payable
|
22,139
|
|
19,925
|
|
2,742
|
Deferred revenue and
customer advances
|
318,587
|
|
289,927
|
|
39,895
|
Amounts due to related
parties
|
4,428
|
|
15,164
|
|
2,087
|
Accrued expenses and
other current liabilities
|
143,677
|
|
91,244
|
|
12,556
|
Dividend
payable
|
-
|
|
30,653
|
|
4,218
|
Current operating
lease liabilities
|
1,927
|
|
1,788
|
|
246
|
Total current
liabilities
|
490,758
|
|
448,701
|
|
61,744
|
Non-current
liabilities
|
|
|
|
|
|
Non-current operating
lease liabilities
|
1,933
|
|
1,083
|
|
149
|
Total non-current
liabilities
|
1,933
|
|
1,083
|
|
149
|
Total
liabilities
|
492,691
|
|
449,784
|
|
61,893
|
SHAREHOLDERS'
EQUITY
|
|
|
|
|
|
Ordinary shares (par
value of US$0.0001 per share,
700,000,000 Class A shares authorized as of
December 31, 2023 and June 30, 2024; 125,122,382
Class A shares issued and 119,704,787 outstanding
as
of December 31, 2023; 125,122,382 Class A shares
issued and 117,852,782 outstanding as of June 30,
2024; 200,000,000 Class B shares authorized,
144,000,000 Class B ordinary shares issued and
outstanding as of December 31, 2023 and June 30,
2024; 100,000,000 shares (undesignated)
authorized,
nil shares (undesignated) issued and outstanding as
of
December 31, 2023 and June 30, 2024)
|
185
|
|
185
|
|
25
|
Additional paid-in
capital
|
1,088,628
|
|
995,474
|
|
136,982
|
Treasury
stock
|
(16,665)
|
|
(21,788)
|
|
(2,998)
|
Statutory
reserves
|
8,164
|
|
8,164
|
|
1,123
|
Accumulated other
comprehensive income
|
17,955
|
|
20,549
|
|
2,828
|
Accumulated
deficit
|
(140,463)
|
|
(93,498)
|
|
(12,866)
|
Total shareholders'
equity
|
957,804
|
|
909,086
|
|
125,094
|
Total liabilities
and shareholders' equity
|
1,450,495
|
|
1,358,870
|
|
186,987
|
iHuman Inc.
|
UNAUDITED CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
(Amounts in
thousands of Renminbi ("RMB") and U.S. dollars
("US$")
|
except for number of
shares, ADSs, per share and per ADS data)
|
|
|
For the three months
ended
|
|
For the six months
ended
|
|
June
30,
|
|
March
31,
|
|
June
30,
|
|
June
30,
|
|
June
30,
|
|
June
30,
|
|
June
30,
|
|
2023
|
|
2024
|
|
2024
|
|
2024
|
|
2023
|
|
2024
|
|
2024
|
|
RMB
|
|
RMB
|
|
RMB
|
|
US$
|
|
RMB
|
|
RMB
|
|
US$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
240,993
|
|
235,003
|
|
215,107
|
|
29,600
|
|
506,196
|
|
450,110
|
|
61,938
|
Cost of
revenues
|
(70,160)
|
|
(66,892)
|
|
(63,372)
|
|
(8,720)
|
|
(149,796)
|
|
(130,264)
|
|
(17,925)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
profit
|
170,833
|
|
168,111
|
|
151,735
|
|
20,880
|
|
356,400
|
|
319,846
|
|
44,013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and
development expenses
|
(63,412)
|
|
(67,923)
|
|
(57,219)
|
|
(7,874)
|
|
(125,085)
|
|
(125,142)
|
|
(17,220)
|
Sales and marketing
expenses
|
(40,564)
|
|
(54,995)
|
|
(51,263)
|
|
(7,054)
|
|
(80,999)
|
|
(106,258)
|
|
(14,622)
|
General and
administrative expenses
|
(25,982)
|
|
(27,724)
|
|
(24,426)
|
|
(3,361)
|
|
(52,717)
|
|
(52,150)
|
|
(7,176)
|
Total operating
expenses
|
(129,958)
|
|
(150,642)
|
|
(132,908)
|
|
(18,289)
|
|
(258,801)
|
|
(283,550)
|
|
(39,018)
|
Operating
income
|
40,875
|
|
17,469
|
|
18,827
|
|
2,591
|
|
97,599
|
|
36,296
|
|
4,995
|
Other income,
net
|
8,132
|
|
9,010
|
|
9,410
|
|
1,295
|
|
14,214
|
|
18,420
|
|
2,535
|
Income before income
taxes
|
49,007
|
|
26,479
|
|
28,237
|
|
3,886
|
|
111,813
|
|
54,716
|
|
7,530
|
Income tax
expenses
|
(6,933)
|
|
(4,177)
|
|
(3,574)
|
|
(492)
|
|
(16,093)
|
|
(7,751)
|
|
(1,067)
|
Net
income
|
42,074
|
|
22,302
|
|
24,663
|
|
3,394
|
|
95,720
|
|
46,965
|
|
6,463
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per
ADS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-
Basic
|
0.80
|
|
0.42
|
|
0.47
|
|
0.06
|
|
1.81
|
|
0.89
|
|
0.12
|
-
Diluted
|
0.77
|
|
0.41
|
|
0.45
|
|
0.06
|
|
1.75
|
|
0.86
|
|
0.12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average
number of ADSs:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-
Basic
|
52,804,594
|
|
52,729,148
|
|
52,496,541
|
|
52,496,541
|
|
52,878,535
|
|
52,612,845
|
|
52,612,845
|
-
Diluted
|
54,725,528
|
|
54,691,599
|
|
54,295,419
|
|
54,295,419
|
|
54,744,139
|
|
54,493,509
|
|
54,493,509
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total share-based
compensation expenses included in:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of
revenues
|
70
|
|
40
|
|
26
|
|
4
|
|
168
|
|
66
|
|
9
|
Research and
development expenses
|
1,142
|
|
457
|
|
348
|
|
48
|
|
1,780
|
|
805
|
|
111
|
Sales and marketing
expenses
|
59
|
|
46
|
|
45
|
|
6
|
|
438
|
|
91
|
|
13
|
General and
administrative expenses
|
1,160
|
|
301
|
|
392
|
|
54
|
|
2,452
|
|
693
|
|
95
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
iHuman Inc.
|
UNAUDITED
RECONCILIATION OF GAAP AND NON-GAAP RESULTS
|
|
(Amounts in
thousands of Renminbi ("RMB") and U.S. dollars
("US$")
|
except for number of
shares, ADSs, per share and per ADS data)
|
|
|
For the three months
ended
|
|
For the six months
ended
|
|
June
30,
|
|
March
31,
|
|
June
30,
|
|
June
30,
|
|
June
30,
|
|
June
30,
|
|
June
30,
|
|
2023
|
|
2024
|
|
2024
|
|
2024
|
|
2023
|
|
2024
|
|
2024
|
|
RMB
|
|
RMB
|
|
RMB
|
|
US$
|
|
RMB
|
|
RMB
|
|
US$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
income
|
40,875
|
|
17,469
|
|
18,827
|
|
2,591
|
|
97,599
|
|
36,296
|
|
4,995
|
Share-based
compensation expenses
|
2,431
|
|
844
|
|
811
|
|
112
|
|
4,838
|
|
1,655
|
|
228
|
Adjusted operating
income
|
43,306
|
|
18,313
|
|
19,638
|
|
2,703
|
|
102,437
|
|
37,951
|
|
5,223
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
income
|
42,074
|
|
22,302
|
|
24,663
|
|
3,394
|
|
95,720
|
|
46,965
|
|
6,463
|
Share-based
compensation expenses
|
2,431
|
|
844
|
|
811
|
|
112
|
|
4,838
|
|
1,655
|
|
228
|
Adjusted net
income
|
44,505
|
|
23,146
|
|
25,474
|
|
3,506
|
|
100,558
|
|
48,620
|
|
6,691
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net income per
ADS
|
0.77
|
|
0.41
|
|
0.45
|
|
0.06
|
|
1.75
|
|
0.86
|
|
0.12
|
Impact of non-GAAP
adjustments
|
0.04
|
|
0.01
|
|
0.02
|
|
0.00
|
|
0.09
|
|
0.03
|
|
0.00
|
Adjusted diluted net
income per ADS
|
0.81
|
|
0.42
|
|
0.47
|
|
0.06
|
|
1.84
|
|
0.89
|
|
0.12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number
of ADSs – diluted
|
54,725,528
|
|
54,691,599
|
|
54,295,419
|
|
54,295,419
|
|
54,744,139
|
|
54,493,509
|
|
54,493,509
|
Weighted average
number of ADSs – adjusted
|
54,725,528
|
|
54,691,599
|
|
54,295,419
|
|
54,295,419
|
|
54,744,139
|
|
54,493,509
|
|
54,493,509
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-announces-second-quarter-2024-unaudited-financial-results-302260944.html
SOURCE iHuman Inc.